School entry requirements and coverage of nontargeted adolescent vaccines

Pediatrics

Volumn 138, Issue 6, 2016, Pages

  Moss, Jennifer L ^a   Reiter, Paul L ^b   Truong, Young K ^a   Rimer, Barbara K ^a,c   Brewer, Noel T ^a,c  

^a IL   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; MENINGOCOCCUS VACCINE; WART VIRUS VACCINE;

ADOLESCENT; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DIPHTHERIA; EDUCATION; FEMALE; HEALTH PROMOTION; HUMAN; INFECTION PREVENTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; OUTCOME ASSESSMENT; PAPILLOMAVIRUS INFECTION; PERTUSSIS; PRIORITY JOURNAL; SCHOOL ENTRY REQUIREMENT; TETANUS; VACCINATION; CHILD HEALTH CARE; IMMUNIZATION; SCHOOL; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADOLESCENT; ADOLESCENT HEALTH SERVICES; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; MALE; PAPILLOMAVIRUS VACCINES; SCHOOL ADMISSION CRITERIA; SCHOOLS; UNITED STATES; VACCINATION;

EID: 85008319103     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2016-1414     Document Type: Article

References (42)

1. Centers for Disease Control and Prevention (CDC). Recommendations and Guidelines: Advisory Committee on Immunization Practices. Updated 2016. Available at: www.cdc.gov/vaccines/acip/index.html
2. Reagan-Steiner S, Yankey D, Jeyarajah J, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years: United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64(29):784-792
3. President's Cancer Panel. Accelerating HPV Vaccine Uptake: Urgency for Action to Prevent Cancer. Updated 2014. Available at: http://deainfo.nci.nih.gov/advisory/pcp/annualReports/HPV/PDF/PCP-Annual-Report-2012-2013.pdf
4. Stokley S, Jeyarajah J, Yankey D, et al Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014: United States. MMWR Morb Mortal Wkly Rep. 2014;63(29):620-624
5. Gellin B, Landry S. The value of vaccines: our nation's front line against infectious diseases. Clin Pharmacol Ther. 2010;88(5):580-581
6. Markowitz LE, Dunne EF, Saraiya M, et al; Centers for Disease Control and Prevention (CDC). Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2014;63(RR-05):1-30
7. Immunization Action Coalition. State Information: State Mandates on Immunization and Vaccine-Preventable Diseases. Updated 2016. Available at: www.immunize.org/laws/
8. Colgrove J, Lowin A. A tale of two states: Mississippi, West Virginia, and exemptions to compulsory school vaccination laws. Health Aff (Millwood). 2016;35(2):348-355
9. Schwartz JL, Easterling LA. State vaccination requirements for HPV and other vaccines for adolescents, 1990-2015. JAMA. 2015;314(2):185-186
10. National Conference on State Legislatures. HPV Vaccine: State Legislation and Statutes. Updated 2016. Available at: www.ncsl.org/default.aspx?tabid=14381
11. Sull M, Eavey J, Papadouka V, Mandell R, Hansen MA, Zucker JR. Adolescent vaccine co-administration and coverage in New York City: 2007-2013. Pediatrics. 2014;134(6). Available at: www.pediatrics.org/cgi/content/full/134/6/e1576
12. Bugenske E, Stokley S, Kennedy A, Dorell C. Middle school vaccination requirements and adolescent vaccination coverage. Pediatrics. 2012;129(6):1056-1063
13. Wilson TR, Fishbein DB, Ellis PA, Edlavitch SA. The impact of a school entry law on adolescent immunization rates. J Adolesc Health. 2005;37(6):511-516
14. Centers for Disease Control and Prevention (CDC). Effectiveness of a middle school vaccination law: California, 1999-2001. MMWR Morb Mortal Wkly Rep. 2001;50(31):660-663
15. Simpson JE, Hills RA, Allwes D, Rasmussen L. Uptake of meningococcal vaccine in Arizona schoolchildren after implementation of school-entry immunization requirements. Public Health Rep. 2013;128(1):37-45
16. Kharbanda EO, Stockwell MS, Colgrove J, Natarajan K, Rickert VI. Changes in Tdap and MCV4 vaccine coverage following enactment of a statewide requirement of Tdap vaccination for entry into sixth grade. Am J Public Health. 2010;100(9):1635-1640
17. Dempsey AF, Schaffer SE. Human papillomavirus vaccination rates and state mandates for tetanuscontaining vaccines. Prev Med. 2011;52(3-4):268-269
18. Noronha AS, Markowitz LE, Dunne EF. Systematic review of human papillomavirus vaccine coadministration. Vaccine. 2014;32(23):2670-2674
19. Charo RA. Politics, parents, and prophylaxis: mandating HPV vaccination in the United States. N Engl J Med. 2007;356(19):1905-1908
20. Schwartz JL, Caplan AL, Faden RR, Sugarman J. Lessons from the failure of human papillomavirus vaccine state requirements. Clin Pharmacol Ther. 2007;82(6):760-763
21. Gilkey MB, Brewer NT. Mandatory HPV vaccination. JAMA. 2012;307(3):252-253, author reply 254-255
22. Bylander J. The United States' piecemeal approach to vaccine policy. Health Aff (Millwood). 2016;35(2):195-198
23. Cuff RD, Buchanan T, Pelkofski E, Korte J, Modesitt SP, Pierce JY. Rates of human papillomavirus vaccine uptake amongst girls five years after introduction of statewide mandate in Virginia. Am J Obstet Gynecol. 2016;214(6):752.e1-752.e6 10.1016/j. ajog.2016
24. Perkins RB, Lin M, Wallington SF, Hanchate AD. Impact of school-entry and education mandates by states on HPV vaccination coverage: analysis of the 2009-2013 National Immunization Survey-Teen. Hum Vaccin Immunother. 2016;12(6):1615-1622
25. Gertig DM, Brotherton JM, Budd AC, Drennan K, Chappell G, Saville AM. Impact of a population-based HPV vaccination program on cervical abnormalities: A data linkage study. BMC Med. 2013;11:227
26. Stokley S, Cohn A, Jain N, McCauley MM. Compliance with recommendations and opportunities for vaccination at ages 11 to 12 years: evaluation of the 2009 National Immunization Survey-Teen. Arch Pediatr Adolesc Med. 2011;165(9):813-818
27. Centers for Disease Control and Prevention (CDC). National Immunization Survey: Datasets for the National Immunization Survey-Teen. Updated 2016. Available at: www.cdc.gov/nchs/nis/data-files-teen. htm
28. Centers for Disease Control and Prevention (CDC). National, state, and local area vaccination coverage among adolescents aged 13-17 years: United States, 2008. MMWR Morb Mortal Wkly Rep. 2009;58(36):997-1001
29. Centers for Disease Control and Prevention (CDC). National, state, and local area vaccination coverage among adolescents aged 13-17 years: United States, 2009. MMWR Morb Mortal Wkly Rep. 2010;59(32):1018-1023
30. Centers for Disease Control and Prevention (CDC). National and state vaccination coverage among adolescents aged 13 through 17 years: United States, 2010. MMWR Morb Mortal Wkly Rep. 2011;60(33):1117-1123
31. Centers for Disease Control and Prevention (CDC). National and state vaccination coverage among adolescents aged 13-17 years: United States, 2011. MMWR Morb Mortal Wkly Rep. 2012;61(34):671-677
32. Centers for Disease Control and Prevention (CDC). National and state vaccination coverage among adolescents aged 13-17 years: United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(34):685-693
33. Moss JL, Reiter PL, Rimer BK, Ribisl KM, Brewer NT. Summer peaks in uptake of human papillomavirus and other adolescent vaccines in the United States. Cancer Epidemiol Biomarkers Prev. 2016;25(2):274-281
34. Edwards JH. The recognition and estimation of cyclic trends. Ann Hum Genet. 1961;25:83-87
35. Centers for Disease Control and Prevention (CDC). Recommendations on the use of quadrivalent human papillomavirus vaccine in males: Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60(50):1705-1708
36. Blank NR, Caplan AL, Constable C. Exempting schoolchildren from immunizations: states with few barriers had highest rates of nonmedical exemptions. Health Aff (Millwood). 2013;32(7):1282-1290
37. Washburn T, Devi Wold A, Raymond P, Duggan-Ball S, Marceau K, Beardsworth A. Current initiatives to protect Rhode Island adolescents through increasing HPV vaccination. Hum Vaccin Immunother. 2016;12(6):1633-1638
38. Hall MG, Sheeran P, Noar SM, Ribisl KM, Bach LE, Brewer NT. Reactance to health warnings scale: development and validation. Ann Behav Med. 10.1007/s12160-016-9799-3
39. Omer SB, Pan WK, Halsey NA, et al. Nonmedical exemptions to school immunization requirements: secular trends and association of state policies with pertussis incidence. JAMA. 2006;296(14):1757-1763
40. Reiter PL, McRee AL, Pepper JK, Brewer NT. Default policies and parents' consent for school-located HPV vaccination. J Behav Med. 2012;35(6):651-657
41. Briss PA, Rodewald LE, Hinman AR, et al; The Task Force on Community Preventive Services. Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. Am J Prev Med. 2000;18(1 suppl):97-140
42. Brewer NT, Moss JL. Herd immunity and the herd severity effect. Lancet Infect Dis. 2015;15(8):868-869